On July 21, 2014, the countdown officially began to disclose results in Europe on the EudraCT website.
For those looking to disclose results, here are 5 reasons to disclose them on ClinicalTrials.gov first and use TrialScope Convert to seed your EudraCT disclosure.
Most companies have been using ClinicalTrials.gov for clinical trial dsiclosure and clinical trial results disclosure for several years. The information is understood and familiar; many have the process of disclosing results down to an art.
Whether you use the PRS data entry interface run by the NIH or a vendor solution, the tools for disclosing results have been around for a while and get the job done. The EudraCT interface is relatively new, and they are still working out the kinks.
Review by a human
When you disclose results at ClinicalTrials.gov, a human looks over your disclosure to see if it makes sense. EudraCT doesn’t have this quality step (at least not yet).
Familiarity with the data and established tools make collecting and entering your results data move faster. Once you convert your disclosure to the EudraCT format, you only have to focus on the differences. One contact estimated this would save 5-8 hours of work per study.
ClinicalTrials.gov is the de facto standard for disclosing clinical trial information. Many companies chose to disclose on ClinicalTrials.gov in addition to wherever else disclosure is required to give a single place where all public disclosures are available.
Would you like to try TrialScope Convert? Click the button below to try our free conversion service that takes a clinicaltrials.gov results xml file and converts it to the format required for EudraCT.
Check out additional white papers, case studies and other tools on the Resources page of our website!